Guardant Health, Inc.
guardanthealth.comAI Executive Summary
AI-powered analysis of 10-Q filing content
Guardant Health shows severe financial deterioration with stockholders' deficit indicating liabilities exceed assets by over $181M. The company experienced a dramatic $710M reduction in short-term marketable securities while convertible debt remains at $1.5B, creating substantial liquidity and solvency concerns for this precision oncology company.
Red Flags Detected (5)
Stockholders' deficit of $181.1M indicates company is technically insolvent
Massive 86% decline in short-term marketable securities from $823M to $113M
Heavy convertible debt burden of $1.5B against deteriorating equity position
2 more red flags detected
Key Takeaways
Company appears to be burning through marketable securities at unsustainable rate
Significant debt overhang with $1.5B convertible notes against negative equity
2 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.